Affimed Nv Stock Probability of Future Stock Price Finishing Over 24.22

AFMD Stock  USD 1.29  0.02  1.57%   
Affimed NV's future price is the expected price of Affimed NV instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Affimed NV performance during a given time horizon utilizing its historical volatility. Check out Affimed NV Backtesting, Affimed NV Valuation, Affimed NV Correlation, Affimed NV Hype Analysis, Affimed NV Volatility, Affimed NV History as well as Affimed NV Performance.
For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.
  
At present, Affimed NV's Price To Book Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 1.87, whereas Price Earnings Ratio is forecasted to decline to (0.84). Please specify Affimed NV's target price for which you would like Affimed NV odds to be computed.

Affimed NV Target Price Odds to finish over 24.22

The tendency of Affimed Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 24.22  or more in 90 days
 1.29 90 days 24.22 
close to zero percent
Based on a normal probability distribution, the odds of Affimed NV to move over $ 24.22  or more in 90 days from now is close to zero percent (This Affimed NV probability density function shows the probability of Affimed Stock to fall within a particular range of prices over 90 days) . Probability of Affimed NV price to stay between its current price of $ 1.29  and $ 24.22  at the end of the 90-day period is about 98.0 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.35 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Affimed NV will likely underperform. Additionally Affimed NV has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Affimed NV Price Density   
       Price  

Predictive Modules for Affimed NV

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Affimed NV. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.061.156.96
Details
Intrinsic
Valuation
LowRealHigh
0.122.468.27
Details
8 Analysts
Consensus
LowTargetHigh
5.506.046.70
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.02-0.99-0.9
Details

Affimed NV Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Affimed NV is not an exception. The market had few large corrections towards the Affimed NV's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Affimed NV, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Affimed NV within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-1.3
β
Beta against Dow Jones2.35
σ
Overall volatility
0.74
Ir
Information ratio -0.22

Affimed NV Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Affimed NV for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Affimed NV can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Affimed NV generated a negative expected return over the last 90 days
Affimed NV has high historical volatility and very poor performance
Affimed NV may become a speculative penny stock
Affimed NV has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 8.28 M. Net Loss for the year was (105.94 M) with profit before overhead, payroll, taxes, and interest of 42.87 M.
Affimed NV currently holds about 237.23 M in cash with (110.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.59, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Affimed NV has a frail financial position based on the latest SEC disclosures
Latest headline from finance.yahoo.com: Affimed Reports Positive Clinical Update on AFM24Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer

Affimed NV Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Affimed Stock often depends not only on the future outlook of the current and potential Affimed NV's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Affimed NV's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding14.9 M
Cash And Short Term Investments72.9 M

Affimed NV Technical Analysis

Affimed NV's future price can be derived by breaking down and analyzing its technical indicators over time. Affimed Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Affimed NV. In general, you should focus on analyzing Affimed Stock price patterns and their correlations with different microeconomic environments and drivers.

Affimed NV Predictive Forecast Models

Affimed NV's time-series forecasting models is one of many Affimed NV's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Affimed NV's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Affimed NV

Checking the ongoing alerts about Affimed NV for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Affimed NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Affimed NV generated a negative expected return over the last 90 days
Affimed NV has high historical volatility and very poor performance
Affimed NV may become a speculative penny stock
Affimed NV has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 8.28 M. Net Loss for the year was (105.94 M) with profit before overhead, payroll, taxes, and interest of 42.87 M.
Affimed NV currently holds about 237.23 M in cash with (110.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.59, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Affimed NV has a frail financial position based on the latest SEC disclosures
Latest headline from finance.yahoo.com: Affimed Reports Positive Clinical Update on AFM24Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer
When determining whether Affimed NV is a strong investment it is important to analyze Affimed NV's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Affimed NV's future performance. For an informed investment choice regarding Affimed Stock, refer to the following important reports:
Check out Affimed NV Backtesting, Affimed NV Valuation, Affimed NV Correlation, Affimed NV Hype Analysis, Affimed NV Volatility, Affimed NV History as well as Affimed NV Performance.
For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Affimed NV. If investors know Affimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Affimed NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.73)
Revenue Per Share
0.493
Quarterly Revenue Growth
(0.90)
Return On Assets
(0.49)
Return On Equity
(1.24)
The market value of Affimed NV is measured differently than its book value, which is the value of Affimed that is recorded on the company's balance sheet. Investors also form their own opinion of Affimed NV's value that differs from its market value or its book value, called intrinsic value, which is Affimed NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Affimed NV's market value can be influenced by many factors that don't directly affect Affimed NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Affimed NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Affimed NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Affimed NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.